Skip to content
Screener

CONMED CNMD Other operating expenses

Other operating expenses at other companies

Stryker logo
StrykerSYK
$2.84B+4.1%
Boston Scientific logo
Boston ScientificBSX
$2.51B+9.8%
Vericel logo
VericelVCEL
$55.97M+15.1%
OSI Systems logo
OSI SystemsOSIS
$97.11M+3.2%
Medtronic logo
MedtronicMDT
-$260M
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$50.57M-7.6%

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.47B-9.4%
Enterprise value$2.45B-1.1%
P/E26×+11.3×
P/S1.1×-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Gross profit197,458188,320380,905366,071
Selling and administrative expense145,553136,021287,252284,868
Research and development expense15,50014,13831,83327,084
Operating expenses161,053150,159319,085311,952
Income from operations36,40538,16161,82054,119
Interest expense7,8837,82414,94316,110
Other (income) / expense(2,825)418(2,825)418
Income before income taxes31,34729,91949,70237,591

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's other operating expenses?
CONMED (CNMD) reported other operating expenses of $161.05M in Q2 2026.
How has CONMED's other operating expenses changed year-over-year?
CONMED's other operating expenses increased by 7.3% year-over-year, from $150.16M to $161.05M.
What is the long-term trend for CONMED's other operating expenses?
Over 4 years (2021 to 2025), CONMED's other operating expenses has grown at a 9.0% compound annual growth rate (CAGR), from $458.32M to $647.85M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about CONMED's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude